GlassScriptPhysician profile
Garish K Alexander
NPI 1902007917
$184,179.61
in general payments reported to CMS, 2019-2025
21 companies · $27K in 2025
The $27K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,599 · 2021: $42K · 2022: $86K · 2023: $5,574 · 2024: $7,079 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $28K · Travel and Lodging: $5,924 · Food and Beverage: $4,792 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $28,150.00 |
| Travel and Lodging | $5,923.59 |
| Food and Beverage | $4,791.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $167,627.77 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Davol INC. | $4,397.14 | 2019-2025 | Phasix Mesh |
| Stryker Corporation | $4,298.72 | 2019-2023 | Aim (Advanced Imaging Modality), Spy-Phi System, 1588 |
| Allergan, INC. | $4,113.48 | 2019-2022 | |
| Abbvie INC. | $2,269.11 | 2024 | |
| Ethicon US, LLC | $777.03 | 2019-2024 | Echelon Flex, Echelon; Endopath |
| Covidien LP | $183.74 | 2020 | |
| Haemonetics Corporation | $90.44 | 2023 | Teg6s Hemostasis System |
| Tela Bio, INC. | $63.81 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endogastric Solutions, INC | $54.57 | 2021 | |
| Heron Therapeutics, INC. | $50.67 | 2022-2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $49.23 | 2025 | Exparel |
| Medtronic, INC. | $37.23 | 2024 | Ligasure |
| Kerecis Limited | $30.74 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Fisher & Paykel Healthcare INC | $27.79 | 2024 | Fisher & Paykel Healthcare |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $22.90 | 2022 | |
| Acell, INC. | $20.00 | 2019 | |
| Phathom Pharmaceuticals, INC. | $19.85 | 2024 | Voquezna |
| Baxter Healthcare | $18.41 | 2019 | |
| Olympus America INC. | $15.07 | 2019 | |
| Medical Device Business Services, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garish Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.